Scilex Holding (SCLX) Other Working Capital Changes (2021 - 2026)

Scilex Holding (SCLX) posted quarterly Other Working Capital Changes of $1.6 million for Q1 2026, up 1351.16% year-over-year from $111221.2 in Q1 2025, and down 76.3% on a QoQ basis from $6.8 million in Q4 2025.

Scilex Holding (SCLX) Other Working Capital Changes (2021 - 2026) Analysis & Trends

Scilex Holding (SCLX) has reported Other Working Capital Changes for 6 consecutive years, with $1.6 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Other Working Capital Changes rose 1351.16% year-over-year to $1.6 million; the TTM figure through Mar 2026 stood at $1.7 million (up 241.9% YoY), while the FY2025 annual figure was -$13000.0, down 101.97% from the prior year.
  • Other Working Capital Changes came in at $1.6 million for Q1 2026 at Scilex Holding, down from $6.8 million in the prior quarter.
  • The five-year high for Other Working Capital Changes was $6.8 million in Q4 2025, with the low at -$6.9 million in Q3 2025.
  • Average Other Working Capital Changes over 5 years is $309250.0, with a median of $116500.0 recorded in 2024.
  • The largest YoY upside for Other Working Capital Changes was 2431.6% in 2025 against a maximum downside of 2135.4% in 2025.
  • Year by year, Other Working Capital Changes stood at -$849000.0 in 2022, then rose by 20.61% to -$674000.0 in 2023, then surged by 139.91% to $269000.0 in 2024, then soared by 2431.6% to $6.8 million in 2025, then tumbled by 76.3% to $1.6 million in 2026.
  • According to Business Quant data, Other Working Capital Changes over the past three periods registered $1.6 million, $6.8 million, and -$6.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn -
10 Scilex Holding 54.30 Mn -95.62 Mn 4.15 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.61 Mn
Mar 31, 2026 1.61 Mn
Mar 31, 2026 1.61 Mn
Dec 31, 2025 6.81 Mn
Dec 31, 2025 6.81 Mn
Dec 31, 2025 6.81 Mn
Sep 30, 2025 -6.90 Mn
Sep 30, 2025 -6.90 Mn
Sep 30, 2025 -6.90 Mn
Jun 30, 2025 206,000.00
Jun 30, 2025 206,000.00
Jun 30, 2025 206,000.00
Mar 31, 2025 -129,000.00
Mar 31, 2025 -129,000.00
Mar 31, 2025 -129,000.00
Dec 31, 2024 269,000.00
Dec 31, 2024 269,000.00
Dec 31, 2024 269,000.00
Sep 30, 2024 339,000.00
Sep 30, 2024 339,000.00